Seeking Alpha

Biotech Analysis Central Model 10+ Portfolio Pick #9 Immunic; Phase 2 CALLIPER Data PMS, Possible Phase 3 Path Forward Vidofludimus Calcium, RMS ENSURE Studies Completed 2026 ...

The next article I wanted to discuss for the Biotech Analysis Central Model 10+ Portfolio Pick #9 is a biotech by the name of Immunic (IMUX). The reason why I believe that it is important to go over ...
Seeking Alpha

Biotech Analysis Central Model 10+ Portfolio Old Pick#17 And Removed: Tempest Therapeutics; Phase 3 Study May Proceed TPST-1120, TPST-1495 Data 2025 And Catalysts

The next article I wanted to discuss for the Biotech Analysis Central Model 10+ Portfolio Old Pick #17 is a biotech by the name of Tempest Therapeutics (TPST). I want to state that I have chosen to ...